In this issue:
Probability of AS response to TNF inhibitor therapy
Immune responses to SARS-CoV-2 vaccines in rituximab recipients
Anifrolumab organ domain effects in moderate-to-severe SLE
Subcutaneous tanezumab for osteoarthritis
Long-term abatacept for primary Sjögren's syndrome
Diverticulitis and gastrointestinal perforation with tocilizumab
Anti-citrullinated protein antibody and gene expression effects of abatacept and adalimumab
Employment, work productivity, and biologic treatments in axial SpA
COVID-19 outcomes after anti-CD20 monoclonal antibody treatment
Please login below to download this issue (PDF)